Sort
11,323 grants matching “glioblastoma”
STUDYING EGFR INTERACTING PARTNERS
$1,167Harold E Varmus · Rockefeller University · P41 · FY2010 · RR
CLINICAL TRIAL: LCCC 0424: PHASE I ERLOTINIB GIVEN EVERY 72 HOURS TO PATIENTS W
$1,148Frances Collichio · Univ Of North Carolina Chapel Hill · M01 · FY2008 · RR
Immunology & Cancer Immunotherapy (ICI)
$1,120Charles L Sentman · Dartmouth College · P30 · FY2017 · CA
Sphingolipid Signaling in Wilms' Tumor Cells
$1,000Fernando Anthony Ferrer · Connecticut Children'S Medical Center · K08 · FY2008 · DK
PH II TRL OF EMD 121974 RCURRENT GLIOBLASTOMA CLIN TRIAL W/TISSUE CORRELATE RESP
$999University Of Pittsburgh At Pittsburgh · M01 · FY2005 · RR
PHASE II STUDY OF XRT + LOW-DOSE TEMOZOLOMIDE FOLLOWED BY TEMOZOLOMIDE + CPT-11
$949Minesh P. Mehta · University Of Wisconsin-Madison · M01 · FY2007 · RR
ZD1839 FOR MALIGNANT ASTROCYTOMA OR GLIOBLASTOMA AND MENINGIOMA
$931University Of California San Francisco · M01 · FY2005 · RR
PROTEOMIC OVERVIEW OF GLIOBLASTOMA CELLS EXPOSED TO PERILLYL ALCOHOL
$839John Robert Yates · University Of Washington · P41 · FY2010 · RR
Regulation of glioma stem cell malignancy by neural activity in the tumor niche
$711Julia Pollak · Seattle Children'S Hospital · F32 · FY2017 · CA
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
$704Ana Krtolica · Omniox, Inc. · R01 · FY2020 · CA
Research Training Program in Neuro-Oncology
$664Brian Patrick O'Neill · Mayo Clinic Rochester · T32 · FY2014 · NS
ZD1839 for Malignant Astrocytoma or Glioblastoma and Meningioma
$609University Of California San Francisco · M01 · FY2004 · RR
PHASE I/II TRIAL OF ZD1839 (IRESSA) IN PEDIATRIC PATIENTS WITH BRAIN STEM TUMORS
$586Susan M Blaney · Baylor College Of Medicine · M01 · FY2007 · RR
ZD1839 for Recurrent/ Progressive Malig Astrocytoma, Glioblastoma, &Meningioma
$508University Of Michigan At Ann Arbor · M01 · FY2004 · RR
PHASE II TRIAL OF EMD 121974 FOR RECURRENT GLIOBLASTOMA
$491Minesh P. Mehta · University Of Wisconsin-Madison · M01 · FY2007 · RR
Phase II Trial of CCI-779 in Recurrent Glioblastoma
$464Mayo Clinic · M01 · FY2004 · RR
CLINICAL TRIAL: ARSENIC TRIOXIDE AND STEREOTACTIC RADIOSURGERY/RADIOTHERAPY FOR
$341Iris Catrice Gibbs · Stanford University · M01 · FY2008 · RR
MARIMASTAT IN PATIENTS W/ GLIOBLASTOMA MULTIFORME OF GLIOSARCOMA
$206University Of Michigan At Ann Arbor · M01 · FY2000 · RR
SU101 VERSUS PROCARBAZINE FOR FIRST RELAPSE PATIENTS W/ GLIOBLASTOMA
$206University Of Michigan At Ann Arbor · M01 · FY2000 · RR
TEMOZOLOMIDE &BCNU FOR ANAPLASTIC GLIOMAS
$206University Of Michigan At Ann Arbor · M01 · FY2000 · RR
Neurologic Oncology
$168Frank Patrick McCormick · University Of California, San Francisco · P30 · FY2016 · CA
Neurologic Oncology
$163Frank Patrick McCormick · University Of California, San Francisco · P30 · FY2015 · CA
Neurologic Oncology
$146Frank Patrick McCormick · University Of California, San Francisco · P30 · FY2012 · CA
Neurologic Oncology
$143Frank Patrick McCormick · University Of California, San Francisco · P30 · FY2014 · CA
A PHASE I STUDY OF ABT-888, AN ORAL INHIBITOR OF POLY
$59Susan M Blaney · Baylor College Of Medicine · M01 · FY2011 · RR